PEPFAR's biggest success is also its largest liability

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)184-185
Number of pages2
JournalThe Lancet
Volume374
Issue number9685
DOIs
StatePublished - 2009

Fingerprint

Organizational Objectives
International Cooperation
Program Development
Patient Dropouts
Medication Adherence
Health Services Needs and Demand
Politics
Developing Countries
Acquired Immunodeficiency Syndrome
Global Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

PEPFAR's biggest success is also its largest liability. / Navario, Peter.

In: The Lancet, Vol. 374, No. 9685, 2009, p. 184-185.

Research output: Contribution to journalArticle

@article{04dacd41206940d7bbe6b9221e0742b4,
title = "PEPFAR's biggest success is also its largest liability",
author = "Peter Navario",
year = "2009",
doi = "10.1016/S0140-6736(09)61312-X",
language = "English (US)",
volume = "374",
pages = "184--185",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9685",

}

TY - JOUR

T1 - PEPFAR's biggest success is also its largest liability

AU - Navario, Peter

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=67650514077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650514077&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(09)61312-X

DO - 10.1016/S0140-6736(09)61312-X

M3 - Article

VL - 374

SP - 184

EP - 185

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9685

ER -